Ujjwal Ramtekkar - Mar 6, 2025 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief Medical Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Stock symbol
LFST
Transactions as of
Mar 6, 2025
Transactions value $
-$49,669
Form type
4
Date filed
3/10/2025, 08:46 PM
Previous filing
Mar 12, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award $0 +57.1K +91.5% $0.00 120K Mar 6, 2025 Direct F1
transaction LFST Common Stock Award $0 +20.8K +17.41% $0.00 140K Mar 7, 2025 Direct F2
transaction LFST Common Stock Tax liability -$49.7K -6.54K -4.66% $7.59 134K Mar 7, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 57,107 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025.
F3 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.